Dechra Pharm PLC (DPH) - Holding(s) in Company RNS Number : 2099E Dechra Pharmaceuticals PLC 28 May 2012 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES^i 1. Identity of the issuer or the underlying issuer Dechra Pharmaceuticals Plc of existing shares to which voting rights are attached: ^ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights ü An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the Schroders plc notification obligation: ^iii 4. Full name of shareholder(s) (if different from 3.):^iv 5. Date of the transaction and date on which the threshold is crossed or 24.05.12 reached: ^v 6. Date on which issuer notified: 25.05.12 7. Threshold(s) that is/are crossed or 11% - 13% reached: ^vi, vii 8. Notified details: A: Voting rights attached to shares ^viii, ix Class/type of Situation previous Resulting situation after the triggering shares to the triggering transaction transaction if possible Number Number Number Number of voting % of voting using of of of shares rights rights ^x the ISIN CODE Shares Voting Direct Direct Indirect Direct Indirect Rights ^xi ^xii Ordinary GB0009633180 13,630,410 9,981,410 16,370,249 N/A 12,082,549 N/A 13.913% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date ^xiii Conversion Period rights that may be rights ^xiv acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^xv, xvi Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date ^xvii Conversion rights instrument rights ^xix, instrument period refers to xx ^xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 12,082,549 13.913% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi Schroder Investment Management Limited 11,473,070 13.211% Schroder Investment Management North America Limited 609,479 0.702% Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. 14. Contact name: Liz Friedman 15. Contact telephone number: 020 7658 6000 This information is provided by RNS The company news service from the London Stock Exchange END HOLDMGZKNRRGZZG -0- May/28/2012 07:52 GMT
Dechra Pharm PLC DPH Holding(s) in Company
Press spacebar to pause and continue. Press esc to stop.